Ubs Oconnor LLC Roivant Sciences Ltd. Transaction History
Ubs Oconnor LLC
- $1.51 Billion
- Q4 2024
A detailed history of Ubs Oconnor LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ubs Oconnor LLC holds 179,266 shares of ROIV stock, worth $1.9 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
179,266Holding current value
$1.9 Million% of portfolio
0.14%Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$696 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$657 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$506 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$466 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$374 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.45B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...